PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsSelenomethionine se-75
Selenomethionine se-75
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
47 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Autoimmune thyroiditisD013967EFO_0006812E06.3—1—135
Hashimoto diseaseD050031EFO_0003779E06.3—1—135
ThyroiditisD013966—E06———134
Liver diseasesD008107EFO_0001421K70-K77———112
Non-alcoholic fatty liver diseaseD065626EFO_0003095K75.81———1—1
Fatty liverD005234EFO_0003934————1—1
AsthmaD001249EFO_0000270J45———1—1
RhinitisD012220EFO_0008521J31———1—1
Allergic conjunctivitisD003233EFO_0007141H10.44———1—1
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Prostatic neoplasmsD011471—C61232—18
Colorectal neoplasmsD015179——112——4
NeoplasmsD009369—C801—1—13
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.9——1—23
Obstructive lung diseasesD008173————1—23
Precancerous conditionsD011230————2——2
Non-small-cell lung carcinomaD002289———11——2
Lung neoplasmsD008175—C34.90—11——2
InfectionsD007239EFO_0000544———1——1
Hiv infectionsD015658EFO_0000764B20——1——1
Show 9 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Renal cell carcinomaD002292EFO_0000376—22———2
Ulcerative colitisD003093EFO_0000729K51—1——12
ColitisD003092EFO_0003872K52.9—1——12
Kidney neoplasmsD007680EFO_0003865C6411———1
Rectal neoplasmsD012004———1———1
Adenocarcinoma of lungD000077192———1———1
Bronchiolo-alveolar adenocarcinomaD002282———1———1
Squamous cell carcinoma of head and neckD000077195———1———1
Squamous cell carcinomaD002294———1———1
XerostomiaD014987—K11.7—1———1
Show 5 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
DiseaseD004194EFO_0000408R691————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FibrosisD005355——————22
Impulsive behaviorD007175——————11
InfertilityD007246EFO_0000545—————11
PregnancyD011247EFO_0002950Z33.1————11
InflammationD007249MP_0001845—————11
Graves diseaseD006111EFO_0004237E05.0————11
HyperthyroidismD006980—E05.9————11
Facioscapulohumeral muscular dystrophyD020391EFO_0000491G71.02————11
Motor activityD009043EFO_0003940—————11
Nutritional requirementsD009751——————11
Show 3 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,200 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
0 adverse events reported
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use